Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fasching, P. A.
1549  Ergebnisse:
Personensuche X
?
1

196P Surgical axillary intervention after neoadjuvant syste..:

Warnecke, F. ; Schneeweiss, A. ; Fasching, P.A....
ESMO Open.  9 (2024)  - p. 103218 , 2024
Link: https://doi.org/10.1016/..
 
?
2

54P Real-world data of patients with recurrent BRCA-mutated..:

Marmé, F. ; Hilpert, F. ; Welslau, M.K....
ESMO Open.  9 (2024)  - p. 103561 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Neoadjuvant pembrolizumab or placebo + chemotherapy, follow..:

Cardoso, F. ; O'Shaughnessy, J. ; McArthur, H....
European Journal of Cancer.  200 (2024)  - p. 113608 , 2024
Link: https://doi.org/10.1016/..
 
?
4

LBA1 Denosumab added to 2 different nab-paclitaxel regimens..:

Loibl, S. ; Reinisch, M. ; Just, M....
ESMO Open.  9 (2024)  - p. 103478 , 2024
Link: https://doi.org/10.1016/..
 
?
5

216P What is driving treatment decision following 1st line ..:

Lüftner, D.I. ; Brucker, C. ; Dawkins, L.S.M....
ESMO Open.  9 (2024)  - p. 103238 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Long-term outcomes of a randomized, open-label, phase II st..:

Meyer-Wilmes, P. ; Huober, J. ; Untch, M....
ESMO Open.  9 (2024)  5 - p. 103009 , 2024
Link: https://doi.org/10.1016/..
 
?
7

P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + ..:

Kümmel, S. ; Schmid, P. ; Harbeck, N....
The Breast.  68 (2023)  - p. S63-S64 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Updated overall survival from the MONALEESA-3 trial in post..:

Neven, P. ; Fasching, P. A. ; Chia, S....
Breast Cancer Research.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
9

Significantly longer time to deterioration of quality of li..:

Harbeck, N. ; Fasching, P.A. ; Wuerstlein, R....
Annals of Oncology.  34 (2023)  8 - p. 660-669 , 2023
Link: https://doi.org/10.1016/..
 
?
10

203P Clinical effectiveness of olaparib in BRCA-mutated, HE..:

Gelmon, K.A. ; Fasching, P.A. ; Delaloge, S....
ESMO Open.  8 (2023)  1 - p. 101392 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Patient-reported outcomes and hospitalization data in patie..:

Curigliano, G. ; Dunton, K. ; Rosenlund, M....
Annals of Oncology.  34 (2023)  7 - p. 569-577 , 2023
Link: https://doi.org/10.1016/..
 
?
12

195P Impact of an interactive eHealth system for patient re..:

Harbeck, N. ; Kates, R.E. ; Schinköthe, T....
ESMO Open.  8 (2023)  1 - p. 101384 , 2023
Link: https://doi.org/10.1016/..
 
?
13

99P Exploratory analysis of differential gene expression (D..:

Denkert, C. ; Nowicka, M. ; Basik, M....
ESMO Open.  8 (2023)  1 - p. 101323 , 2023
Link: https://doi.org/10.1016/..
 
?
14

154TiP TACTIVE-N: Open-label, randomized, noncomparative ne..:

Fasching, P.A. ; Clifton, K. ; Katashvili, Z....
ESMO Open.  8 (2023)  1 - p. 101493 , 2023
Link: https://doi.org/10.1016/..
 
?
15

222P Real-world clinical outcomes among patients (pts) with..:

Hall, P.S. ; Chang, L. ; Parikh, R....
ESMO Open.  8 (2023)  1 - p. 101411 , 2023
Link: https://doi.org/10.1016/..
 
1-15